Protein Folding: From Biology to AI Therapeutics
Received: 01-May-2025 / Manuscript No. cmb-25-174585 / Editor assigned: 05-May-2025 / PreQC No. cmb-25-174585 / Reviewed: 19-May-2025 / QC No. cmb-25-174585 / Revised: 22-May-2025 / Manuscript No. cmb-25-174585 / Published Date: 29-May-2025
Abstract
This collection explores protein folding and misfolding, revealing the crucial role of molecular chaperones in maintaining proteome integrity and the pathogenesis of neurodegenerative diseases. It delves into co-translational folding, cellular stress responses like ISR and ER quality control, and the revolutionary impact of AI in protein structure prediction. The data also covers advanced single-molecule and computational methods that elucidate folding landscapes and kinetics. The emerging landscape of small molecule therapeutics targeting protein misfolding pathways offers promising strategies for conditions like Alzheimer’s, Parkinson’s, and cystic fibrosis.
Keywords
Protein Folding; Protein Misfolding; Molecular Chaperones; Neurodegenerative Diseases; AlphaFold; Cellular Stress Response; ER Quality Control; Amyloid Formation; Machine Learning; Drug Discovery
Introduction
The fundamental process of protein folding is critical for cellular function, with molecular chaperones playing an indispensable role in guiding nascent proteins to their correct native structures and refolding denatured ones. This crucial assistance prevents misfolding and aggregation, especially when cells are under stress, thereby maintaining overall proteome integrity [1].
However, protein misfolding is a central mechanism in the pathogenesis of various neurodegenerative diseases, including Alzheimer's, Parkinson's, and Huntington's. These conditions often share common molecular underpinnings like protein aggregation and subsequent cellular toxicity, prompting active research into therapeutic strategies that specifically target these misfolded proteins [2].
Further complicating the folding landscape is the phenomenon of co-translational protein folding, where polypeptide chains begin to acquire their three-dimensional structures even before their complete synthesis on the ribosome. This intricate process involves a dynamic interplay between translation kinetics, the crucial involvement of chaperone proteins, and the immediate local cellular environment, all of which direct efficient and accurate folding pathways [3].
In a significant breakthrough for structural biology and drug discovery, the AI system AlphaFold achieved unprecedented accuracy in protein structure prediction. This system, detailed through its sophisticated neural network architecture and training regimen, has effectively addressed the long-standing protein folding problem, demonstrating capabilities often matching experimental methods and fundamentally transforming the field [4].
Cells respond to stressors, such as the accumulation of misfolded proteins in the endoplasmic reticulum, through mechanisms like the integrated stress response (ISR). This vital cellular pathway globally attenuates protein synthesis while selectively promoting the translation of specific messenger RNAs, serving as a critical feedback loop to restore cellular homeostasis and enable adaptation to stressful conditions [5].
Amyloid formation, a process central to many debilitating protein misfolding diseases, involves complex molecular mechanisms. This process typically transitions from soluble proteins to highly ordered fibrillar aggregates, with studies detailing the thermodynamic and kinetic principles involved. Understanding these fundamental steps is key to linking amyloid formation to disease pathology and informing potential therapeutic interventions [6].
Advancements in single-molecule techniques, particularly those utilizing fluorescence-based methods, have enabled detailed probing of protein folding landscapes. These innovative approaches provide unparalleled insights by revealing transient intermediates and identifying parallel folding pathways, aspects often obscured in traditional bulk experiments. They offer a unique window into the energy landscape and dynamic transitions that govern protein folding processes [7].
Endoplasmic Reticulum (ER) quality control mechanisms are also paramount for proper protein folding and secretion. This intricate system involves ER-resident chaperones, the Unfolded Protein Response (UPR), and ER-Associated Degradation (ERAD), all working in concert to maintain proteostasis. Dysregulation in these pathways is frequently implicated in the development of various diseases, highlighting their importance in cellular health [8].
Computational approaches, specifically the synergistic application of machine learning and molecular simulations, have proven invaluable in exploring the complex energy landscape of protein folding. These advanced tools offer detailed insights into folding kinetics, pathways, and intermediates at an atomic level, significantly advancing our theoretical understanding of how proteins precisely attain their native functional states [9].
Finally, the development of small molecule therapeutics offers a promising avenue for intervening in protein misfolding diseases. These therapeutic strategies encompass a range of approaches, including molecules designed to stabilize native protein conformations, inhibit pathogenic aggregation, or enhance the cellular protein quality control machinery. Such innovations offer considerable hope for treating widespread conditions like Alzheimer's, Parkinson's, and cystic fibrosis [10].
Description
Protein folding is a cornerstone of cellular biology, essential for proteins to achieve their functional three-dimensional structures. Molecular chaperones are central to this process, acting as cellular assistants to prevent misfolding and aggregation, particularly under stressful conditions. They guide nascent proteins and refold denatured ones, ensuring proteome integrity [1]. The complexity extends to co-translational protein folding, where synthesis on the ribosome and folding occur simultaneously, influenced by translation dynamics, chaperone involvement, and the immediate cellular environment to ensure efficient and accurate pathways [3].
The detrimental consequences of protein misfolding are strikingly evident in neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's. Here, the common molecular mechanisms often involve the aggregation of misfolded proteins, leading to cellular toxicity. Understanding these pathways is crucial for developing targeted therapeutic strategies [2]. This aggregation process, particularly amyloid formation, has been extensively studied, detailing the intricate steps from soluble proteins to highly ordered fibrillar aggregates. The thermodynamics and kinetics involved provide a critical link between these fundamental processes and disease pathology, guiding interventions [6].
Cells possess sophisticated mechanisms to counteract protein misfolding. The Integrated Stress Response (ISR) is a vital pathway activated by stressors, including the accumulation of misfolded proteins within the Endoplasmic Reticulum (ER). The ISR functions by globally attenuating protein synthesis while specifically promoting the translation of certain mRNAs, thereby restoring cellular homeostasis [5]. Complementary to ISR, the ER quality control system, involving ER-resident chaperones, the Unfolded Protein Response (UPR), and ER-Associated Degradation (ERAD), is indispensable for proper protein folding and secretion. Dysregulation of these pathways has clear links to various disease states, emphasizing their importance in maintaining proteostasis [8].
The field has seen transformative advancements in both experimental and computational methodologies. Single-molecule techniques, especially fluorescence-based methods, now allow researchers to probe protein folding landscapes with unprecedented detail. These approaches reveal transient intermediates and parallel folding pathways that are often obscured in bulk experiments, offering deep insights into the energy landscape and dynamic transitions governing protein folding [7]. On the computational front, AlphaFold, an AI system, has achieved remarkable accuracy in protein structure prediction, often matching experimental results. Its neural network architecture has effectively addressed the long-standing protein folding problem, profoundly impacting structural biology and drug discovery [4]. The synergistic application of machine learning and molecular simulations further enhances our ability to navigate the complex energy landscape, providing atomic-level insights into folding kinetics, pathways, and intermediates, thereby advancing our theoretical understanding of protein native states [9].
Building on these scientific insights, the development of small molecule therapeutics represents a key emerging area for addressing protein misfolding diseases. These strategies focus on diverse mechanisms, such as stabilizing the native states of proteins, inhibiting the formation of aggregates, or augmenting the cellular protein quality control machinery. Such innovative approaches hold significant promise for treating debilitating conditions including Alzheimer's, Parkinson's, and cystic fibrosis [10].
Conclusion
Protein folding is a core biological process, with molecular chaperones playing a crucial role in ensuring proteins achieve their correct native structures and preventing misfolding, especially under stress. Misfolding can lead to severe issues, notably in neurodegenerative diseases like Alzheimer's and Parkinson's, where protein aggregation and cellular toxicity are central mechanisms. Co-translational folding further highlights the complexity of this process, influenced by translation dynamics and cellular environment. Recent advancements include AI systems like AlphaFold, which have revolutionized protein structure prediction, transforming structural biology. Cellular mechanisms such as the Integrated Stress Response (ISR) and Endoplasmic Reticulum (ER) quality control systems (including the Unfolded Protein Response and ER-Associated Degradation) are vital for maintaining proteostasis and responding to misfolded protein accumulation. Researchers are also exploring amyloid formation pathways, leveraging single-molecule techniques to probe folding landscapes, and employing machine learning with molecular simulations to understand kinetics and pathways at an atomic level. These insights are paving the way for developing small molecule therapeutics that target protein misfolding, aiming to stabilize native states or inhibit aggregation in various diseases.
References
- F. UH, Manajit H, Karin H (2021) Protein Folding and the Central Role of Molecular Chaperones.Front Mol Biosci 8:731776.
- Rubén R, José AR, María EG (2020) Protein Misfolding in Neurodegenerative Diseases: A Current Overview.Cells 9:1990.
- Luís DC, Nicolas L, Jérôme N (2021) Co-translational protein folding: when, where, and how.Nat Rev Mol Cell Biol 22:614-633.
- John J, Richard E, Alexander P (2021) Highly accurate protein structure prediction with AlphaFold.Nature 596:583-589.
- Katarzyna P, Ilona K, Katarzyna M (2019) The integrated stress response and its modulation in health and disease.Nat Rev Mol Cell Biol 20:721-735.
- Federica M, Chiara C, Andile S (2020) Amyloid formation: from molecular mechanism to disease.Chem Soc Rev 49:5084-5114.
- María RR, Kaley R, Abigail P (2022) Single-molecule analysis of protein folding landscapes.Curr Opin Struct Biol 72:236-243.
- Jing R, Xiaofei Y, Mingming S (2023) Molecular mechanisms of ER quality control in health and disease.Physiol Rev 103:2219-2268.
- Andreas P, Mustafa C, Manuel S (2022) Exploring the Protein Folding Energy Landscape with Machine Learning and Molecular Simulations.Acc Chem Res 55:519-528.
- Paolo A, David CM, Takaaki T (2022) Small Molecules Targeting Protein Misfolding Diseases.Trends Pharmacol Sci 43:457-471.
Citation: Keller DM (2025) Protein Folding: From Biology to AI Therapeutics. cmb 71: 385.
Copyright: © 2025 Dr. Martin Keller This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 57
- [From(publication date): 0-0 - Dec 20, 2025]
- Breakdown by view type
- HTML page views: 38
- PDF downloads: 19
